AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 33165588 — intervention group
Group type: EXPERIMENTAL
Intervention: Urban location of facilities and presence of a medical officer
Number of subjects: 60
Study 33186306 — intervention group
Group type: EXPERIMENTAL
Intervention: Continuous CPAP through a Boussignac system
Number of subjects: 422
Study 33186306 — intervention group
Group type: COMPARATOR
Intervention: Standard care
Number of subjects: 422
Study 33491360 — intervention group
Group type: EXPERIMENTAL
Intervention: Role-play training
Number of subjects: 46
Study 34619676 — intervention group
Group type: EXPERIMENTAL
Intervention: Moisturizer containing 10% urea and additional NMF components
Number of subjects: 66
Study 34619676 — intervention group
Group type: COMPARATOR
Intervention: Vehicle
Number of subjects: 66
Study 34325019 — intervention group
Group type: EXPERIMENTAL
Intervention: Early cholecystectomy
Number of subjects: 98
Study 34325019 — intervention group
Group type: COMPARATOR
Intervention: Control (cholecystectomy after clinical resolution)
Number of subjects: 98
Study 35854371 — intervention group
Group type: EXPERIMENTAL
Intervention: Insecticide-treated eave nets (ITENs) and insecticide-treated window screens (ITWS) installed
Number of subjects: 450
Study 35854371 — intervention group
Group type: COMPARATOR
Intervention: No intervention (control group)
Number of subjects: 450
Study 33760713 — intervention group
Group type: EXPERIMENTAL
Intervention: Accelerated speaking valve placement (⩽24 h)
Number of subjects: 20
Study 33760713 — intervention group
Group type: COMPARATOR
Intervention: Standard speaking valve placement (⩾48 h)
Number of subjects: 20
Study 33760713 — intervention group
Group type: EXPERIMENTAL
Intervention: Both arms (Accelerated and Standard)
Number of subjects: 20
Study 35656475 — intervention group
Group type: EXPERIMENTAL
Intervention: Bacterial cellulose (BC) dressing
Number of subjects: 212
Study 35656475 — intervention group
Group type: COMPARATOR
Intervention: Vaseline gauze (VG) dressing
Number of subjects: 212
Study 34344427 — intervention group
Group type: EXPERIMENTAL
Intervention: Green tea extract (450 mg, two capsules twice a day for 14 days)
Number of subjects: 74
Study 34344427 — intervention group
Group type: COMPARATOR
Intervention: Placebo (two capsules twice a day for 14 days)
Number of subjects: 74
Study 36096458 — intervention group
Group type: EXPERIMENTAL
Intervention: Anodal tDCS intervention (1.5 mA for 20 min)
Number of subjects: 15
Study 36096458 — intervention group
Group type: EXPERIMENTAL
Intervention: Cathodal tDCS intervention
Number of subjects: 15
Study 36096458 — intervention group
Group type: COMPARATOR
Intervention: Sham condition
Number of subjects: 15
Study 34213544 — intervention group
Group type: EXPERIMENTAL
Intervention: High-dose prenatal plus postpartum vitamin D (28,000 IU per week)
Number of subjects: 1174
Study 34213544 — intervention group
Group type: COMPARATOR
Intervention: Placebo (0 IU vitamin D per week)
Number of subjects: 1174
Study 35452918 — intervention group
Group type: EXPERIMENTAL
Intervention: Personalised approach with a physiotherapist who actively listened and provided a bespoke multimodal regimen
Number of subjects: 33
Study 32130184 — intervention group
Group type: EXPERIMENTAL
Intervention: Nurse coaching and mobile health (mHealth) technology
Number of subjects: 319
Study 32130184 — intervention group
Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 319
Study 33672229 — intervention group
Group type: EXPERIMENTAL
Intervention: BeFAB app (n = 65)
Number of subjects: 136
Study 33672229 — intervention group
Group type: COMPARATOR
Intervention: Usual care (n = 71)
Number of subjects: 136
Study 32853703 — intervention group
Group type: EXPERIMENTAL
Intervention: Neurofeedback (NF)
Number of subjects: 144
Study 32853703 — intervention group
Group type: COMPARATOR
Intervention: Control (prerecorded electroencephalograms with participant's artifacts)
Number of subjects: 144
Study 33491110 — intervention group
Group type: EXPERIMENTAL
Intervention: Emdogain (Straumann, Basel, Switzerland)
Number of subjects: 60
Study 33491110 — intervention group
Group type: EXPERIMENTAL
Intervention: Curodont Repair (Credentis AG, Switzerland)
Number of subjects: 60
Study 33491110 — intervention group
Group type: EXPERIMENTAL
Intervention: Duraphat (Colgate‐Palmolive, New York, NY)
Number of subjects: 60
Study 33491110 — intervention group
Group type: EXPERIMENTAL
Intervention: Clinpro XT (3 M ESPE, Pymble, New South Wales, Australia)
Number of subjects: 60
Study 33491110 — intervention group
Group type: EXPERIMENTAL
Intervention: Enamel Pro Varnish (Premier Dental Products, PA, USA)
Number of subjects: 60
Study 33491110 — intervention group
Group type: COMPARATOR
Intervention: Control (untreated)
Number of subjects: 60
Study 34246303 — intervention group
Group type: EXPERIMENTAL
Intervention: LOW (1.5 g/kg carbohydrate, 3.0 g/kg fat)
Number of subjects: 11
Study 34246303 — intervention group
Group type: COMPARATOR
Intervention: AD (6.0 g/kg carbohydrate, 1.0 g/kg fat)
Number of subjects: 11
Study 34246303 — intervention group
Group type: EXPERIMENTAL
Intervention: LOW
Number of subjects: 11
Study 34246303 — intervention group
Group type: COMPARATOR
Intervention: AD
Number of subjects: 11
Study 34246303 — intervention group
Group type: EXPERIMENTAL
Intervention: Both LOW and AD
Number of subjects: 11
Study 35410284 — intervention group
Group type: EXPERIMENTAL
Intervention: Mindfulness-based interventions (MBIs)
Number of subjects: 135
Study 35410284 — intervention group
Group type: COMPARATOR
Intervention: Relaxation interventions
Number of subjects: 135
Study 35410284 — intervention group
Group type: COMPARATOR
Intervention: No session-introducing intervention
Number of subjects: 135
Study 33256456 — intervention group
Group type: EXPERIMENTAL
Intervention: Real TEAS at PC6 for 20 min at 2 Hz frequency and 6 mA intensity
Number of subjects: 32
Study 33256456 — intervention group
Group type: COMPARATOR
Intervention: Sham TEAS (control) with zero frequency/intensity
Number of subjects: 32
Study 32179929 — intervention group
Group type: EXPERIMENTAL
Intervention: Intensive rehabilitation programme in a warm climate (17-day duration)
Number of subjects: 64
Study 32179929 — intervention group
Group type: COMPARATOR
Intervention: Usual care with no structured rehabilitation
Number of subjects: 64
Study 36424664 — intervention group
Group type: EXPERIMENTAL
Intervention: 3.000-m run in the morning (7:00-8:00 a.m.)
Number of subjects: 15
Study 36424664 — intervention group
Group type: COMPARATOR
Intervention: 3.000-m run in the evening (7:00-8:00 p.m.)
Number of subjects: 15
Study 36424664 — intervention group
Group type: EXPERIMENTAL
Intervention: Incremental treadmill test in the morning (7:00-8:00 a.m.)
Number of subjects: 15
Study 36424664 — intervention group
Group type: COMPARATOR
Intervention: Incremental treadmill test in the evening (7:00-8:00 p.m.)
Number of subjects: 15
Study 34945234 — intervention group
Group type: EXPERIMENTAL
Intervention: Remote hospital care including oxygen therapy, medication, and remote monitoring.
Number of subjects: 62
Study 34945234 — intervention group
Group type: COMPARATOR
Intervention: In-hospital care as usual (control group).
Number of subjects: 62
Study 35662283 — intervention group
Group type: EXPERIMENTAL
Intervention: Nivolumab (nivo) with chemotherapy (gemcitabine/nab-paclitaxel)
Number of subjects: 105
Study 35662283 — intervention group
Group type: EXPERIMENTAL
Intervention: Sotigalimab (sotiga) with chemotherapy (gemcitabine/nab-paclitaxel)
Number of subjects: 105
Study 35662283 — intervention group
Group type: EXPERIMENTAL
Intervention: Sotigalimab (sotiga) with nivolumab (nivo) and chemotherapy (gemcitabine/nab-paclitaxel)
Number of subjects: 105
Study 33761458 — intervention group
Group type: EXPERIMENTAL
Intervention: High-Intensity Interval Training (HIIT)
Number of subjects: 45
Study 33761458 — intervention group
Group type: EXPERIMENTAL
Intervention: Aerobic Training
Number of subjects: 45
Study 33761458 — intervention group
Group type: COMPARATOR
Intervention: Control Group
Number of subjects: 45
Study 32179792 — intervention group
Group type: EXPERIMENTAL
Intervention: Intraoperative ATP (8 impulses à 6 Volt x 1.0 milliseconds)
Number of subjects: 150
Study 32179792 — intervention group
Group type: COMPARATOR
Intervention: Without intraoperative ATP
Number of subjects: 150
Study 32179792 — intervention group
Group type: COMPARATOR
Intervention: Without ATP
Number of subjects: 150
Study 32179792 — intervention group
Group type: EXPERIMENTAL
Intervention: With ATP
Number of subjects: 150
Study 36342113 — intervention group
Group type: EXPERIMENTAL
Intervention: Pemafibrate (0.2-mg tablets twice daily)
Number of subjects: 10497
Study 36342113 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 10497
Study 36342113 — intervention group
Group type: EXPERIMENTAL
Intervention: Pemafibrate
Number of subjects: 10497
Study 36342113 — intervention group
Group type: COMPARATOR
Intervention: Pemafibrate vs Placebo
Number of subjects: 10497
Study 33277288 — intervention group
Group type: EXPERIMENTAL
Intervention: Continuous skin-to-skin contact
Number of subjects: 11
Study 33277288 — intervention group
Group type: COMPARATOR
Intervention: Not applicable
Number of subjects: 11
Study 33323188 — intervention group
Group type: EXPERIMENTAL
Intervention: Chat-based instant messaging support for 3 months, offers of referral to external smoking cessation services, and brief advice.
Number of subjects: 1185
Study 33323188 — intervention group
Group type: COMPARATOR
Intervention: Brief advice alone (control group).
Number of subjects: 1185
Study 34501540 — intervention group
Group type: EXPERIMENTAL
Intervention: Multifaceted intervention program (interactive oral activities, tongue strength training, oral cleaning procedure)
Number of subjects: 41
Study 34501540 — intervention group
Group type: COMPARATOR
Intervention: Phase 1 (usual activities, baseline data collection)
Number of subjects: 41
Study 32601641 — intervention group
Group type: EXPERIMENTAL
Intervention: Methicillin‐Resistant Staphylococcus aureus (MRSA)
Number of subjects: 250
Study 32601641 — intervention group
Group type: EXPERIMENTAL
Intervention: Infected burn injuries
Number of subjects: 250
Study 33615398 — intervention group
Group type: EXPERIMENTAL
Intervention: CBT combined with medication (CBT + M)
Number of subjects: 98
Study 33615398 — intervention group
Group type: COMPARATOR
Intervention: Medication only (M)
Number of subjects: 98
Study 33291973 — intervention group
Group type: EXPERIMENTAL
Intervention: Basic implementation strategy via an internal coordinator
Number of subjects: 10
Study 33291973 — intervention group
Group type: EXPERIMENTAL
Intervention: Depression services implementation via an internal coordinator and an external quality assurance committee
Number of subjects: 10
Study 33291973 — intervention group
Group type: COMPARATOR
Intervention: Both intervention packages
Number of subjects: 10
Study 32846334 — intervention group
Group type: EXPERIMENTAL
Intervention: High-altitude pulmonary rehabilitation (HAPR)
Number of subjects: 138
Study 32846334 — intervention group
Group type: COMPARATOR
Intervention: Sea-level pulmonary rehabilitation (LAPR)
Number of subjects: 138
Study 34813962 — intervention group
Group type: EXPERIMENTAL
Intervention: Telemedicine access to specialty medical care
Number of subjects: 624
Study 34813962 — intervention group
Group type: COMPARATOR
Intervention: Usual care (offsite specialty referral)
Number of subjects: 624
Study 32881148 — intervention group
Group type: EXPERIMENTAL
Intervention: Desire thinking
Number of subjects: 60
Study 32881148 — intervention group
Group type: COMPARATOR
Intervention: Neutral thinking
Number of subjects: 60
Study 35266842 — intervention group
Group type: EXPERIMENTAL
Intervention: Posttraumatic Growth Inventory (PTGI)
Number of subjects: 616
Study 35266842 — intervention group
Group type: EXPERIMENTAL
Intervention: Stress-Related Growth Scale (SRGS)
Number of subjects: 616
Study 35266842 — intervention group
Group type: EXPERIMENTAL
Intervention: Guided-steps version of the SRGS
Number of subjects: 616
Study 35266842 — intervention group
Group type: COMPARATOR
Intervention: Original SRGS
Number of subjects: 616
Study 34347808 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral phloroglucinol (Flospan®)
Number of subjects: 142
Study 34347808 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 142
Study 32600320 — intervention group
Group type: EXPERIMENTAL
Intervention: Lactose challenge (50 g lactose)
Number of subjects: 40
Study 32600320 — intervention group
Group type: EXPERIMENTAL
Intervention: Conventional milk (750 mL, 37.5 g lactose)
Number of subjects: 40
Study 32600320 — intervention group
Group type: EXPERIMENTAL
Intervention: A1 β-casein-free milk (a2 Milk™) (750 mL, 37.5 g lactose)
Number of subjects: 40
Study 32600320 — intervention group
Group type: EXPERIMENTAL
Intervention: Existing literature cut-off values for breath H2
Number of subjects: 40
Study 32600320 — intervention group
Group type: EXPERIMENTAL
Intervention: Breath H2 optimal cut-off value
Number of subjects: 40
Study 36195894 — intervention group
Group type: EXPERIMENTAL
Intervention: Digital fetal scalp stimulation (dFSS)
Number of subjects: 2500
Study 36195894 — intervention group
Group type: COMPARATOR
Intervention: Fetal blood sampling (FBS)
Number of subjects: 2500
Study 34445008 — intervention group
Group type: EXPERIMENTAL
Intervention: Aerobic exercise + weight loss (AEX + WL)
Number of subjects: 100
Study 34445008 — intervention group
Group type: COMPARATOR
Intervention: Weight loss (WL)
Number of subjects: 100
Study 33422174 — intervention group
Group type: EXPERIMENTAL
Intervention: Methotrexate monotherapy 20 mg once a week
Number of subjects: 1
Study 33422174 — intervention group
Group type: COMPARATOR
Intervention: Hydroxychloroquine 400 mg daily with topical minoxidil
Number of subjects: 1
Study 35843459 — intervention group
Group type: EXPERIMENTAL
Intervention: Vitamin D (60,000 IU every 5 days)
Number of subjects: 59
Study 35843459 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 59
Study 33866774 — intervention group
Group type: EXPERIMENTAL
Intervention: DPP-4 inhibitor (gemigliptin)
Number of subjects: 0
Study 33866774 — intervention group
Group type: COMPARATOR
Intervention: DPP-4 inhibitor (sitagliptin)
Number of subjects: 0
Study 34410358 — intervention group
Group type: EXPERIMENTAL
Intervention: Cipargamin (KAE609) single doses of 50 to 150 mg
Number of subjects: 0
Study 34410358 — intervention group
Group type: COMPARATOR
Intervention: Artemether-lumefantrine (control)
Number of subjects: 0
Study 34410358 — intervention group
Group type: EXPERIMENTAL
Intervention: Cipargamin (KAE609)
Number of subjects: 0
Study 33522951 — intervention group
Group type: EXPERIMENTAL
Intervention: Homeopathy: 1 globule of Natrum muriaticum LM2 diluted in 20 mL of alcohol 30%, taken orally every 4 hours while symptomatic, then every 6 hours until the fourteenth day.
Number of subjects: 100
Study 33522951 — intervention group
Group type: COMPARATOR
Intervention: Placebo: 20 mL of alcohol 30% dispensed in a 30 ml bottle, taken orally every 4 hours while symptomatic, then every 6 hours until the fourteenth day.
Number of subjects: 100
Study 33522951 — intervention group
Group type: EXPERIMENTAL
Intervention: Homeopathy
Number of subjects: 100
Study 33522951 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 100
Study 32515740 — intervention group
Group type: EXPERIMENTAL
Intervention: Coach-guided web-based therapy (The Journal) for 12 weeks
Number of subjects: 95
Study 32515740 — intervention group
Group type: COMPARATOR
Intervention: Information-only waitlist control (leaflet of mental health resources)
Number of subjects: 95
Study 34130573 — intervention group
Group type: EXPERIMENTAL
Intervention: Proactive management with Cal/BD foam (twice-weekly application)
Number of subjects: 0
Study 34130573 — intervention group
Group type: COMPARATOR
Intervention: Reactive management with Cal/BD foam (once-daily for four weeks after relapse)
Number of subjects: 0
Study 34130573 — intervention group
Group type: EXPERIMENTAL
Intervention: Proactive management with Cal/BD foam
Number of subjects: 0
Study 33548084 — intervention group
Group type: EXPERIMENTAL
Intervention: Quadruple single-pill combination (reserpine 0.1 mg, dihydralazine 12.5 mg, hydrochlorothiazide 12.5 mg, triamterene 12.5 mg)
Number of subjects: 60
Study 33548084 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 60
Study 33548084 — intervention group
Group type: EXPERIMENTAL
Intervention: Quadruple single-pill combination
Number of subjects: 60
Study 33548084 — intervention group
Group type: EXPERIMENTAL
Intervention: Both treatment and placebo groups
Number of subjects: 60
Study 33548084 — intervention group
Group type: EXPERIMENTAL
Intervention: Combination group
Number of subjects: 60
Study 33548084 — intervention group
Group type: COMPARATOR
Intervention: Placebo group
Number of subjects: 60
Study 35969408 — intervention group
Group type: EXPERIMENTAL
Intervention: Enhanced self-measured blood pressure (SMBP) using a device paired with a connected smartphone application.
Number of subjects: 2101
Study 35969408 — intervention group
Group type: COMPARATOR
Intervention: Standard self-measured blood pressure (SMBP) device.
Number of subjects: 2101
Study 35969408 — intervention group
Group type: EXPERIMENTAL
Intervention: Enhanced SMBP
Number of subjects: 2101
Study 35969408 — intervention group
Group type: COMPARATOR
Intervention: Standard SMBP
Number of subjects: 2101
Study 33186774 — intervention group
Group type: EXPERIMENTAL
Intervention: 10 % povidone‐iodine vaginal disinfection for 30 s
Number of subjects: 270
Study 33186774 — intervention group
Group type: COMPARATOR
Intervention: No vaginal disinfection (control)
Number of subjects: 270
Study 33186774 — intervention group
Group type: EXPERIMENTAL
Intervention: 10 % povidone‐iodine vaginal disinfection
Number of subjects: 270
Study 36727153 — intervention group
Group type: EXPERIMENTAL
Intervention: Aspirin plus prasugrel
Number of subjects: 76
Study 36727153 — intervention group
Group type: COMPARATOR
Intervention: Aspirin plus clopidogrel
Number of subjects: 76
Study 34677005 — intervention group
Group type: EXPERIMENTAL
Intervention: Hypochlorite-based formula brushing solution
Number of subjects: 40
Study 34677005 — intervention group
Group type: COMPARATOR
Intervention: Chlorhexidine toothpaste and mouthwash
Number of subjects: 40
Study 32969733 — intervention group
Group type: EXPERIMENTAL
Intervention: Hydromorphone 1 mg/kg
Number of subjects: 8
Study 32969733 — intervention group
Group type: EXPERIMENTAL
Intervention: Hydromorphone 2 mg/kg
Number of subjects: 8
Study 32969733 — intervention group
Group type: COMPARATOR
Intervention: Control (saline 0.9% NaCl)
Number of subjects: 8
Study 32969733 — intervention group
Group type: EXPERIMENTAL
Intervention: Hydromorphone 1 mg/kg and 2 mg/kg
Number of subjects: 8
Study 36350593 — intervention group
Group type: EXPERIMENTAL
Intervention: uRDN
Number of subjects: 136
Study 36350593 — intervention group
Group type: COMPARATOR
Intervention: Sham
Number of subjects: 136
Study 33516795 — intervention group
Group type: EXPERIMENTAL
Intervention: Incisional negative pressure wound therapy (NPWT)
Number of subjects: 124
Study 33516795 — intervention group
Group type: COMPARATOR
Intervention: Standard dressing (control)
Number of subjects: 124
Study 33728040 — intervention group
Group type: EXPERIMENTAL
Intervention: Pen included with questionnaire
Number of subjects: 1466
Study 33728040 — intervention group
Group type: COMPARATOR
Intervention: No pen included with questionnaire
Number of subjects: 1466
Study 35654369 — intervention group
Group type: EXPERIMENTAL
Intervention: High-Intensity Interval Training (HIIT)
Number of subjects: 55
Study 35654369 — intervention group
Group type: COMPARATOR
Intervention: Constant-Load Exercise (CLE)
Number of subjects: 55
Study 33547927 — intervention group
Group type: EXPERIMENTAL
Intervention: App-based exercise program (GenuSport)
Number of subjects: 35
Study 33547927 — intervention group
Group type: COMPARATOR
Intervention: Regular physiotherapy (control group)
Number of subjects: 35
Study 32815438 — intervention group
Group type: EXPERIMENTAL
Intervention: Figure-of-eight suture technique (ES group)
Number of subjects: 152
Study 32815438 — intervention group
Group type: COMPARATOR
Intervention: Manual compression (MC group)
Number of subjects: 152
Study 35299213 — intervention group
Group type: EXPERIMENTAL
Intervention: Musical intervention (listening to Music Care application via headphones)
Number of subjects: 72
Study 35299213 — intervention group
Group type: COMPARATOR
Intervention: Standard care (no music)
Number of subjects: 72
Study 35299213 — intervention group
Group type: EXPERIMENTAL
Intervention: Musical intervention
Number of subjects: 72
Study 35299213 — intervention group
Group type: COMPARATOR
Intervention: Standard care
Number of subjects: 72
Study 33427754 — intervention group
Group type: EXPERIMENTAL
Intervention: Continuous warming of human milk (n = 22)
Number of subjects: 44
Study 33427754 — intervention group
Group type: COMPARATOR
Intervention: Hot water bath warming of human milk (n = 22)
Number of subjects: 44
Study 34643944 — intervention group
Group type: EXPERIMENTAL
Intervention: Machine-learning model (XGBoost) for screening cognitive impairment
Number of subjects: 1736
Study 34643944 — intervention group
Group type: EXPERIMENTAL
Intervention: Hypothetical ED model for screening
Number of subjects: 1736
Study 32358216 — intervention group
Group type: EXPERIMENTAL
Intervention: Telephone follow-up
Number of subjects: 0
Study 32358216 — intervention group
Group type: COMPARATOR
Intervention: In-person clinic visits
Number of subjects: 0
Study 34741103 — intervention group
Group type: EXPERIMENTAL
Intervention: Rotarix (live‐attenuated, oral rotavirus vaccine)
Number of subjects: 180
Study 32609331 — intervention group
Group type: EXPERIMENTAL
Intervention: Icosapent Ethyl (IPE) 4 g/day
Number of subjects: 80
Study 32609331 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 80
Study 33054728 — intervention group
Group type: EXPERIMENTAL
Intervention: Fear of falling (FoF) assessed using the Short Falls Efficacy Scale International
Number of subjects: 309
Study 33054728 — intervention group
Group type: EXPERIMENTAL
Intervention: Subjective functional capacity
Number of subjects: 309
Study 33054728 — intervention group
Group type: EXPERIMENTAL
Intervention: Fear of falling (FoF)
Number of subjects: 309
Study 33054728 — intervention group
Group type: EXPERIMENTAL
Intervention: EQ-5D index
Number of subjects: 309
Study 33054728 — intervention group
Group type: EXPERIMENTAL
Intervention: EQ-5D descriptive system and EQ-VAS
Number of subjects: 309
Study 35064942 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 108
Study 35064942 — intervention group
Group type: COMPARATOR
Intervention: Ethanol (approximately 0.7 ml/kg)
Number of subjects: 108
Study 34620496 — intervention group
Group type: EXPERIMENTAL
Intervention: Ceralasertib 160 mg orally daily (days 1-7) and olaparib 300 mg orally twice daily (days 1-28) of a 28-day cycle until toxicity or progression
Number of subjects: 14
Study 34620496 — intervention group
Group type: EXPERIMENTAL
Intervention: Ceralasertib plus olaparib
Number of subjects: 14
Study 35462033 — intervention group
Group type: EXPERIMENTAL
Intervention: Guideline-Directed Medical Therapy (GDMT)
Number of subjects: 150
Study 35462033 — intervention group
Group type: EXPERIMENTAL
Intervention: Angiotensin-converting enzymes/angiotensin receptor blockers/angiotensin receptor-neprilysin inhibitors
Number of subjects: 150